A physician and co-author of the 2021 PRT trial, specializing in pain psychology. Schubiner contributed to PRT’s development, focusing on pain reappraisal and neuroplastic pain assessment, with his work showing PRT’s efficacy in reducing chronic back pain in 66% of patients.
